Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection

Journal of Immunology

Volumn 193, Issue 12, 2014, Pages 6081-6089

  Steigedal, Magnus ^a   Marstad, Anne ^a   Haug, Markus ^a,b   Damås, Jan K ^a,c   Strong, Roland K ^d   Roberts, Pacita L ^e   Himpsl, Stephanie D ^f   Stapleton, Ann ^e   Hooton, Thomas M ^g   Mobley, Harry L T ^f   Hawn, Thomas R ^e   Flo, Trude H ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b Central Norway Regional Health Authority ^*  (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d Fred Hutchinson Cancer Research Center   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBACTIN; CXCL1 CHEMOKINE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 6; IRON BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SIDEROPHORE; TUMOR NECROSIS FACTOR; YERSINIABACTIN; ACUTE PHASE PROTEIN; IRON; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ADULT; ANIMAL CELL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BLADDER; CONTROLLED STUDY; CYSTITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOST RESISTANCE; HUMAN; HUMAN CELL; INNATE IMMUNITY; IRON TRANSPORT; KIDNEY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PREMENOPAUSE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS SAPROPHYTICUS; URETER; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; ADOLESCENT; ANIMAL; BACTERIAL INFECTION; BACTERIAL LOAD; DISEASE MODEL; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MUCOSA; NEUTROPHIL; PATHOLOGY; YOUNG ADULT;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; ANIMALS; BACTERIAL INFECTIONS; BACTERIAL LOAD; CYSTITIS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; HUMANS; IRON; LIPOCALINS; MICE; MIDDLE AGED; MUCOUS MEMBRANE; NEUTROPHIL INFILTRATION; NEUTROPHILS; PROTO-ONCOGENE PROTEINS; SIDEROPHORES; URINARY BLADDER; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84916918509     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401528     Document Type: Article

References (49)

1. Hooton, T. M. 2001. Recurrent urinary tract infection in women. Int. J. Antimicrob. Agents 17: 259-268.
2. Foxman, B. 1990. Recurring urinary tract infection: incidence and risk factors. Am. J. Public Health 80: 331-333.
3. Hooton, T. M., D. Scholes, A. E. Stapleton, P. L. Roberts, C. Winter, K. Gupta, M. Samadpour, and W. E. Stamm. 2000. A prospective study of asymptomatic bacteriuria in sexually active young women. N. Engl. J. Med. 343: 992-997.
4. Anderson, G. G., J. J. Palermo, J. D. Schilling, R. Roth, J. Heuser, and S. J. Hultgren. 2003. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301: 105-107.
5. Schilling, J. D., M. A. Mulvey, C. D. Vincent, R. G. Lorenz, and S. J. Hultgren. 2001. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. J. Immunol. 166: 1148-1155.
6. Samuelsson, P., L. Hang, B. Wullt, H. Irjala, and C. Svanborg. 2004. Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect. Immun. 72: 3179-3186.
7. Song, J., M. J. Duncan, G. Li, C. Chan, R. Grady, A. Stapleton, and S. N. Abraham. 2007. A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog. 3: e60.
8. -/- mice are more susceptible to Escherichia coli urinary tract infection. J. Immunol. 178: 4717-4720.
9. Hooton, T. M., D. Scholes, J. P. Hughes, C. Winter, P. L. Roberts, A. E. Stapleton, A. Stergachis, and W. E. Stamm. 1996. A prospective study of risk factors for symptomatic urinary tract infection in young women. N. Engl. J. Med. 335: 468-474.
10. Scholes, D., T. M. Hooton, P. L. Roberts, A. E. Stapleton, K. Gupta, and W. E. Stamm. 2000. Risk factors for recurrent urinary tract infection in young women. J. Infect. Dis. 182: 1177-1182.
11. Hawn, T. R., D. Scholes, S. S. Li, H. Wang, Y. Yang, P. L. Roberts, A. E. Stapleton, M. Janer, A. Aderem, W. E. Stamm, et al. 2009. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS ONE 4: e5990.
12. Hawn, T. R., D. Scholes, H. Wang, S. S. Li, A. E. Stapleton, M. Janer, A. Aderem, W. E. Stamm, L. P. Zhao, and T. M. Hooton. 2009. Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women. PLoS ONE 4: e8300.
13. Silverman, J. A., H. L. Schreiber, IV, T. M. Hooton, and S. J. Hultgren. 2013. From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections. Curr. Urol. Rep. 14: 448-456.
14. Rosen, D. A., T. M. Hooton, W. E. Stamm, P. A. Humphrey, and S. J. Hultgren. 2007. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med. 4: e329.
15. Nielubowicz, G. R., and H. L. Mobley. 2010. Host-pathogen interactions in urinary tract infection. Nat. Rev. Urol. 7: 430-441.
16. Reigstad, C. S., S. J. Hultgren, and J. I. Gordon. 2007. Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled. J. Biol. Chem. 282: 21259-21267.
17. Ratledge, C., and L. G. Dover. 2000. Iron metabolism in pathogenic bacteria. Annu. Rev. Microbiol. 54: 881-941.
18. Flo, T. H., K. D. Smith, S. Sato, D. J. Rodriguez, M. A. Holmes, R. K. Strong, S. Akira, and A. Aderem. 2004. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432: 917-921.
19. Kjeldsen, L., D. F. Bainton, H. Sengeløv, and N. Borregaard. 1994. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood 83: 799-807.
20. Kjeldsen, L., J. B. Cowland, and N. Borregaard. 2000. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim. Biophys. Acta 1482: 272-283.
21. Goetz, D. H., M. A. Holmes, N. Borregaard, M. E. Bluhm, K. N. Raymond, and R. K. Strong. 2002. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell 10: 1033-1043.
22. Valdebenito, M., A. L. Crumbliss, G. Winkelmann, and K. Hantke. 2006. Environmental factors influence the production of enterobactin, salmochelin, aerobactin, and yersiniabactin in Escherichia coli strain Nissle 1917. Int. J. Med. Microbiol. 296: 513-520.
23. Fischbach, M. A., H. Lin, L. Zhou, Y. Yu, R. J. Abergel, D. R. Liu, K. N. Raymond, B. L. Wanner, R. K. Strong, C. T. Walsh, et al. 2006. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc. Natl. Acad. Sci. USA 103: 16502-16507.
24. Raffatellu, M., M. D. George, Y. Akiyama, M. J. Hornsby, S. P. Nuccio, T. A. Paixao, B. P. Butler, H. Chu, R. L. Santos, T. Berger, et al. 2009. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 5: 476-486.
25. Bachman, M. A., J. E. Oyler, S. H. Burns, M. Caza, F. Lépine, C. M. Dozois, and J. N. Weiser. 2011. Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect. Immun. 79: 3309-3316.
26. Garcia, E. C., A. R. Brumbaugh, and H. L. Mobley. 2011. Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect. Immun. 79: 1225-1235.
27. Henderson, J. P., J. R. Crowley, J. S. Pinkner, J. N. Walker, P. Tsukayama, W. E. Stamm, T. M. Hooton, and S. J. Hultgren. 2009. Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog. 5: e1000305.
28. Chen, S. L., C. S. Hung, J. Xu, C. S. Reigstad, V. Magrini, A. Sabo, D. Blasiar, T. Bieri, R. R. Meyer, P. Ozersky, et al. 2006. Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. Proc. Natl. Acad. Sci. USA 103: 5977-5982.
29. + recycling endocytic pathway and avoid lipocalin 2 trafficking to the lysosomal pathway. J. Infect. Dis. 201: 783-792.
30. Czaja, C. A., W. E. Stamm, A. E. Stapleton, P. L. Roberts, T. R. Hawn, D. Scholes, M. Samadpour, S. J. Hultgren, and T. M. Hooton. 2009. Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women. J. Infect. Dis. 200: 528-536.
31. Hung, C. S., K. W. Dodson, and S. J. Hultgren. 2009. A murine model of urinary tract infection. Nat. Protoc. 4: 1230-1243.
32. Chan, Y. R., J. S. Liu, D. A. Pociask, M. Zheng, T. A. Mietzner, T. Berger, T.W. Mak, M. C. Clifton, R. K. Strong, P. Ray, and J. K. Kolls. 2009. Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J. Immunol. 182: 4947-4956.
33. Hannan, T. J., I. U. Mysorekar, C. S. Hung, M. L. Isaacson-Schmid, and S. J. Hultgren. 2010. Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog. 6: e1001042.
34. Liang, S. C., X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L. A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203: 2271-2279.
35. Rubino, S. J., K. Geddes, and S. E. Girardin. 2012. Innate IL-17 and IL-22 responses to enteric bacterial pathogens. Trends Immunol. 33: 112-118.
36. Østvik, A. E., A. V. Granlund, S. H. Torp, A. Flatberg, V. Beisva˚g, H. L. Waldum, T. H. Flo, T. Espevik, J. K. Dama˚s, and A. K. Sandvik. 2013. Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2. Clin. Exp. Immunol. 173: 502-511.
37. Paragas, N., A. Qiu, Q. Zhang, B. Samstein, S. X. Deng, K. M. Schmidt-Ott, M. Viltard, W. Yu, C. S. Forster, G. Gong, et al. 2011. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat. Med. 17: 216-222.
38. Torres, A. G., P. Redford, R. A. Welch, and S. M. Payne. 2001. TonB-dependent systems of uropathogenic Escherichia coli: aerobactin and heme transport and TonB are required for virulence in the mouse. Infect. Immun. 69: 6179-6185.
39. Brzuszkiewicz, E., H. Brüggemann, H. Liesegang, M. Emmerth, T. Olschläger, G. Nagy, K. Albermann, C. Wagner, C. Buchrieser, L. Emody, et al. 2006. How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc. Natl. Acad. Sci. USA 103: 12879-12884.
40. Hantke, K., G. Nicholson, W. Rabsch, and G. Winkelmann. 2003. Salmochelins, siderophores of Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer membrane receptor IroN. Proc. Natl. Acad. Sci. USA 100: 3677-3682.
41. Watts, R. E., M. Totsika, V. L. Challinor, A. N. Mabbett, G. C. Ulett, J. J. De Voss, and M. A. Schembri. 2012. Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli. Infect. Immun. 80: 333-344.
42. Bachman, M. A., V. L. Miller, and J. N. Weiser. 2009. Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin. PLoS Pathog. 5: e1000622.
43. Yilmaz, A., E. Sevketoglu, A. Gedikbasi, S. Karyagar, A. Kiyak, M. Mulazimoglu, G. Aydogan, T. Ozpacaci, and S. Hatipoglu. 2009. Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin. Pediatr. Nephrol. 24: 2387-2392.
44. Decavele, A. S., L. Dhondt, M. L. De Buyzere, and J. R. Delanghe. 2011. Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturia. Clin. Chem. Lab. Med. 49: 999-1003.
45. Paragas, N., A. Qiu, M. Hollmen, T. L. Nickolas, P. Devarajan, and J. Barasch. 2012. NGAL-Siderocalin in kidney disease. Biochim. Biophys. Acta 1823: 1451-1458.
46. Haug, M., J. A. Awuh, M. Steigedal, J. Frengen Kojen, A. Marstad, I. S. Nordrum, Ø. Halaas, and T. H. Flo. 2013. Dynamics of immune effector mechanisms during infection with Mycobacterium avium in C57BL/6 mice. Immunology 140: 232-243.
47. Aujla, S. J., Y. R. Chan, M. Zheng, M. Fei, D. J. Askew, D. A. Pociask, T. A. Reinhart, F. McAllister, J. Edeal, K. Gaus, et al. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14: 275-281.
48. Cowland, J. B., O. E. Sørensen, M. Sehested, and N. Borregaard. 2003. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1β, but not by TNF-α. J. Immunol. 171: 6630-6639.
49. Spurbeck, R. R., P. C. Dinh, Jr., S. T. Walk, A. E. Stapleton, T. M. Hooton, L. K. Nolan, K. S. Kim, J. R. Johnson, and H. L. Mobley. 2012. Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract. Infect. Immun. 80: 4115-4122.